artigo Esteato-hepatite.p65 - Sociedade de Gastroenterologia do ...
artigo Esteato-hepatite.p65 - Sociedade de Gastroenterologia do ...
artigo Esteato-hepatite.p65 - Sociedade de Gastroenterologia do ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
HESTEATO-HEPATITE NÃO-ALCOÓLICA<br />
29. Bugianesi E, Leone N, Vanni E et al. Expanding the natural history<br />
of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to<br />
hepatocellular carcinoma. Gastroenterology 2002;123:134-40.<br />
30. Harrison SA & Neuschwan<strong>de</strong>r-Tetri BA. Pharmacologic management<br />
of nonalcoholic fatty liver disease. Clin Liver Dis 2004;8:715-28.<br />
31. Weigle DS. Pharmacological therapy of obesity: past, present, and<br />
future. J Clin En<strong>do</strong>crinol Metab 2003; 88:2.462-69.<br />
32. Zelber-Sagi S, Kessler A, Brazowsky E et al. Ran<strong>do</strong>mized placebocontrolled<br />
trial of orlistat for the treatment of patients with non<br />
alcoholic fatty liver disease (NAFLD). Hepatology 2004;40:237A.<br />
33. Dixon JB, Bhathal PS, Hughes NR, O’Brien PE. Nonalcoholic fatty<br />
liver disease: Improvement in liver histological analysis with weight<br />
loss. Hepatology 2004; 39:1.647-1.654.<br />
34. Ludwig J, Laurin J, Lin<strong>do</strong>r KD et al. Urso<strong>de</strong>oxycholic acid or clofibrate<br />
in the treatment of non-alcohol-induced steatohepatitis: a pilot study.<br />
Hepatology 1996;23:1.464-1.467.<br />
35. Lin<strong>do</strong>r KD, Kowdley KV, Heathcote EJ et al. Urso<strong>de</strong>oxycholic acid for<br />
treatment of nonalcoholic steatohepatitis: Results of a ran<strong>do</strong>mized<br />
trial. Hepatology 2004;39:770-778.<br />
36. Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E<br />
and vitamin C treatment improves fibrosis in patients with nonalcoholic<br />
steatohepatitis. Am J Gastroenterol 2003;98:2.485-2.490.<br />
37. Mattos AA, Zamin IJ, Coral GP, Santos DE, Soares EB, Migon EZ.<br />
Antioxidant vitamin E prevents the <strong>de</strong>velopment of nonalcoholic<br />
steatohepatitis (NASH) in rats. J Hepatol 2004;40:174A.<br />
38. Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ,<br />
Guallar E. Meta-Analysis: High-Dosage vitamin E supplementation<br />
may increase all-cause mortality. Ann Intern Med 2005;142:37-46.<br />
39. Neuschwan<strong>de</strong>r-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon<br />
BR. Improved nonalcoholic steatohepatitis after 48 weeks of<br />
treatment with the PPAR- ligand rosiglitazone. Hepatology<br />
2003;38:1.008-1.017.<br />
40. Promrat K, Lutchman G, Uwaifo GI et al. A pilot study of pioglitazone<br />
treatment for nonalcoholic steatohepatitis. Hepatology<br />
2004;39:188-196.<br />
41. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, Melchionda N.<br />
Metformin in non-alcoholic steatohepatitis. Lancet 2001;358:893-4.<br />
42. Yokohama S, Yoneda M, Haneda M et al. Therapeutic efficacy of an<br />
angiotensin II receptor antagonist in patients with nonalcoholic<br />
steatohepatitis. Hepatology 2004;40:1.222-5.<br />
43. Kim WR, Poterucha JJ, Porayko MK et al. Recurrence of nonalcoholic<br />
steatohepatitis following liver transplantation. Transplantation<br />
1996;62:1.802-1.805.<br />
En<strong>de</strong>reço para correspondência<br />
Dr. Angelo Alves <strong>de</strong> Mattos<br />
Rua Professor Anna Dias, 55 / 1.103 - Centro<br />
90020-090 – Porto Alegre - RS<br />
JBG, J. bras. gastroenterol., Rio <strong>de</strong> Janeiro, v.5, n.4, p.160-165, out./<strong>de</strong>z. 2005 165